Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer-Reference-Cited by-同舟云学术

Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer

Published:2022-03 Issue:3 Volume:3 Page:100561
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Hou Zemin,Huang Shengsong,Mei Zejie,Chen Longlong,Guo Jiacheng,Gao Yuanyuan,Zhuang Qian,Zhang Xuebin,Tan Qilong,Yang Tao,Liu Ying,Chi Yongnan,Qi Lifengrong,Jiang Ting,Shao Xuefeng,Wu Yan,Xu Xiaojun,Qin Jun,Ren Ruobing,Tang Huiru,Wu Denglong,Li Zhenfei^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference74 articles.

1. Steroid biosynthesis and prostate cancer;Sharifi;Steroids,2012

2. Androgens in prostate cancer: a tale that never ends;Hou;Cancer Lett.,2021

3. Sex hormones and prostate cancer;Auchus;Annu. Rev. Med.,2020

4. Prostatic cancer treated by orchiectomy; the five year results;Huggins;J. Am. Med. Assoc.,1946

5. Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase);Barrie;J. Steroid Biochem. Mol. Biol.,1994

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor progestins activity: Cytostatic effect and immune response;Steroids;2024-10

2. HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES;Cell Reports Medicine;2024-08

3. Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients;Journal of Experimental & Clinical Cancer Research;2024-05-15

4. Importance of 3β-hydroxysteroid dehydrogenases and their clinical use in prostate cancer;Endocrine-Related Cancer;2024-04-29

5. Steroids in Cancer: Mechanisms, Therapies, and Challenges in Hormone-Driven Malignancies;Interdisciplinary Cancer Research;2024